METiS is a company that uses advanced AI algorithms, quantum mechanics, and molecular dynamics simulations to calculate properties of pharmaceutical ingredients. They also predict interactions and properties of therapeutics in specific environments. This helps with lead optimization, candidate selection, and formulation design. Founded by MIT researchers and industry veterans, METiS develops and licenses assets with high therapeutic potential.